Literature DB >> 22025512

Differential virulence of clinical and bovine-biased enterohemorrhagic Escherichia coli O157:H7 genotypes in piglet and Dutch belted rabbit models.

Smriti Shringi1, Alexis García, Kevin K Lahmers, Kathleen A Potter, Sureshkumar Muthupalani, Alton G Swennes, Carolyn J Hovde, Douglas R Call, James G Fox, Thomas E Besser.   

Abstract

Enterohemorrhagic Escherichia coli O157:H7 (EHEC O157) is an important cause of food and waterborne illness in the developed countries. Cattle are a reservoir host of EHEC O157 and a major source of human exposure through contaminated meat products. Shiga toxins (Stxs) are an important pathogenicity trait of EHEC O157. The insertion sites of the Stx-encoding bacteriophages differentiate EHEC O157 isolates into genogroups commonly isolated from cattle but rarely from sick humans (bovine-biased genotypes [BBG]) and those commonly isolated from both cattle and human patients (clinical genotypes [CG]). Since BBG and CG share the cardinal virulence factors of EHEC O157 and are carried by cattle at similar prevalences, the infrequent occurrence of BBG among human disease isolates suggests that they may be less virulent than CG. We compared the virulence potentials of human and bovine isolates of CG and BBG in newborn conventional pig and weaned Dutch Belted rabbit models. CG-challenged piglets experienced severe disease accompanied by early and high mortality compared to BBG-challenged piglets. Similarly, CG-challenged rabbits were likely to develop lesions in kidney and intestine compared with the BBG-challenged rabbits. The CG strains used in this study carried stx2 and produced significantly higher amounts of Stx, whereas the BBG strains carried the stx2c gene variant only. These results suggest that BBG are less virulent than CG and that this difference in virulence potential is associated with the Stx2 subtype(s) carried and/or the amount of Stx produced.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025512      PMCID: PMC3255674          DOI: 10.1128/IAI.05470-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  72 in total

1.  Verotoxin 2 enhances adherence of enterohemorrhagic Escherichia coli O157:H7 to intestinal epithelial cells and expression of {beta}1-integrin by IPEC-J2 cells.

Authors:  Bianfang Liu; Xianhua Yin; Yanni Feng; James R Chambers; Aiguang Guo; Joshua Gong; Jing Zhu; Carlton L Gyles
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

2.  Greater diversity of Shiga toxin-encoding bacteriophage insertion sites among Escherichia coli O157:H7 isolates from cattle than in those from humans.

Authors:  Thomas E Besser; Nurmohammad Shaikh; Nicholas J Holt; Phillip I Tarr; Michael E Konkel; Preeti Malik-Kale; Coilin W Walsh; Thomas S Whittam; James L Bono
Journal:  Appl Environ Microbiol       Date:  2006-12-01       Impact factor: 4.792

3.  Shiga toxin subtypes display dramatic differences in potency.

Authors:  Cynthia A Fuller; Christine A Pellino; Michael J Flagler; Jane E Strasser; Alison A Weiss
Journal:  Infect Immun       Date:  2011-01-03       Impact factor: 3.441

Review 4.  Zoonotic enterohemorrhagic Escherichia coli: A One Health perspective.

Authors:  Alexis García; James G Fox; Thomas E Besser
Journal:  ILAR J       Date:  2010

5.  Surveillance for foodborne disease outbreaks --- United States, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-08-13       Impact factor: 17.586

6.  Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.

Authors:  Sylvie Nathanson; Thérésa Kwon; Monique Elmaleh; Marina Charbit; Emma Allain Launay; Jérôme Harambat; Muriel Brun; Bruno Ranchin; Flavio Bandin; Sylvie Cloarec; Guylhene Bourdat-Michel; Christine Piètrement; Gérard Champion; Tim Ulinski; Georges Deschênes
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

7.  Role of Escherichia coli O157:H7 virulence factors in colonization at the bovine terminal rectal mucosa.

Authors:  Haiqing Sheng; Ji Youn Lim; Hannah J Knecht; Jie Li; Carolyn J Hovde
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

8.  Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections.

Authors:  Galeb S Abu-Ali; Lindsey M Ouellette; Scott T Henderson; David W Lacher; James T Riordan; Thomas S Whittam; Shannon D Manning
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

9.  Differential expression of virulence and stress fitness genes between Escherichia coli O157:H7 strains with clinical or bovine-biased genotypes.

Authors:  Sivapriya Kailasan Vanaja; Amber C Springman; Thomas E Besser; Thomas S Whittam; Shannon D Manning
Journal:  Appl Environ Microbiol       Date:  2009-10-30       Impact factor: 4.792

10.  Foodborne illness acquired in the United States--major pathogens.

Authors:  Elaine Scallan; Robert M Hoekstra; Frederick J Angulo; Robert V Tauxe; Marc-Alain Widdowson; Sharon L Roy; Jeffery L Jones; Patricia M Griffin
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

View more
  17 in total

1.  Characterization of a novel microcin that kills enterohemorrhagic Escherichia coli O157:H7 and O26.

Authors:  Lauren J Eberhart; James R Deringer; Kelly A Brayton; Ashish A Sawant; Thomas E Besser; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2012-07-06       Impact factor: 4.792

2.  Geographically distinct Escherichia coli O157 isolates differ by lineage, Shiga toxin genotype, and total shiga toxin production.

Authors:  Glen E Mellor; Narelle Fegan; Kari S Gobius; Helen V Smith; Amy V Jennison; Beatriz A D'Astek; Marta Rivas; Smriti Shringi; Katherine N K Baker; Thomas E Besser
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

3.  Lineage and genogroup-defining single nucleotide polymorphisms of Escherichia coli O157:H7.

Authors:  Woo Kyung Jung; James L Bono; Michael L Clawson; Shana R Leopold; Smriti Shringi; Thomas E Besser
Journal:  Appl Environ Microbiol       Date:  2013-09-06       Impact factor: 4.792

Review 4.  Shiga toxin-producing Escherichia coli in swine: the public health perspective.

Authors:  Marion Tseng; Pina M Fratamico; Shannon D Manning; Julie A Funk
Journal:  Anim Health Res Rev       Date:  2014-01-08       Impact factor: 2.615

Review 5.  Role of Shiga/Vero toxins in pathogenesis.

Authors:  Fumiko Obata; Tom Obrig
Journal:  Microbiol Spectr       Date:  2014-06

6.  Multilocus genotype analysis of Escherichia coli O157 isolates from Australia and the United States provides evidence of geographic divergence.

Authors:  Glen E Mellor; Thomas E Besser; Margaret A Davis; Brittany Beavis; Wookyung Jung; Helen V Smith; Amy V Jennison; Christine J Doyle; P Scott Chandry; Kari S Gobius; Narelle Fegan
Journal:  Appl Environ Microbiol       Date:  2013-06-14       Impact factor: 4.792

7.  Enteropathogenic Escherichia coli prevalence in laboratory rabbits.

Authors:  Alton G Swennes; Ellen M Buckley; Carolyn M Madden; Charles P Byrd; Rachel S Donocoff; Loretta Rodriguez; Nicola M A Parry; James G Fox
Journal:  Vet Microbiol       Date:  2013-01-23       Impact factor: 3.293

8.  Enzootic enteropathogenic Escherichia coli infection in laboratory rabbits.

Authors:  Alton G Swennes; Ellen M Buckley; Nicola M A Parry; Carolyn M Madden; Alexis García; Peter B Morgan; Keith M Astrofsky; James G Fox
Journal:  J Clin Microbiol       Date:  2012-05-09       Impact factor: 5.948

9.  GeneSippr: a rapid whole-genome approach for the identification and characterization of foodborne pathogens such as priority Shiga toxigenic Escherichia coli.

Authors:  Dominic Lambert; Catherine D Carrillo; Adam G Koziol; Paul Manninger; Burton W Blais
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

10.  Carriage of stx2a differentiates clinical and bovine-biased strains of Escherichia coli O157.

Authors:  Smriti Shringi; Carrie Schmidt; Kaya Katherine; Kelly A Brayton; Dale D Hancock; Thomas E Besser
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.